Cargando…
Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells
Fatty acid synthase, a key enzyme of de novo lipogenesis, is an attractive therapeutic target in cancer. The novel fatty acid synthase inhibitor, TVB-3664, shows anti-cancer activity in multiple cancers including colorectal cancer; however, it is unclear whether uptake of exogeneous fatty acids can...
Autores principales: | Drury, James, Rychahou, Piotr G., He, Daheng, Jafari, Naser, Wang, Chi, Lee, Eun Y., Weiss, Heidi L., Evers, Bernard Mark, Zaytseva, Yekaterina Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411002/ https://www.ncbi.nlm.nih.gov/pubmed/32850342 http://dx.doi.org/10.3389/fonc.2020.01185 |
Ejemplares similares
-
Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression
por: Drury, James, et al.
Publicado: (2022) -
Activation of c-Met and Upregulation of CD44 Expression Are Associated with the Metastatic Phenotype in the Colorectal Cancer Liver Metastasis Model
por: Elliott, Victoria A., et al.
Publicado: (2014) -
Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration
por: Zaytseva, Yekaterina Y., et al.
Publicado: (2015) -
Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation
por: Sinner, Heather F., et al.
Publicado: (2019) -
Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer
por: Drury, James, et al.
Publicado: (2022)